Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Christine Wasylyk & Bohdan Wasylyk. (2000) Defect in the p53-Mdm2 Autoregulatory Loop Resulting from Inactivation of TAFII250 in Cell Cycle Mutant tsBN462 Cells. Molecular and Cellular Biology 20:15, pages 5554-5570.
Read now
Read now
Articles from other publishers (39)
Faizan Malik, Andrew W. Allbee & Paul J. Zhang. (2023) Intra-Abdominal and Retroperitoneal Benign Lipomatous Tumors—An Extremely Rare Mimic of Liposarcoma and its Diagnostic Challenge. International Journal of Surgical Pathology, pages 106689692311675.
Crossref
Crossref
Fei Fei, Shuko Harada, Shi Wei & Gene P. Siegal. 2022. Bone Cancer. Bone Cancer
579
590
.
Lakshmipathi Vadlakonda, Meera Indracanti, Suresh K. Kalangi, B. Meher Gayatri, Navya G Naidu & Aramati B. M. Reddy. (2020) The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in Diabetes and Cancer. Journal of Diabetes & Metabolic Disorders 19:2, pages 1731-1775.
Crossref
Crossref
David J. OlivosIIIIII, Daniel S. Perrien, Adam Hooker, Ying‐Hua Cheng, Robyn K. Fuchs, Jung Min Hong, Angela Bruzzaniti, Kristin Chun, Christine M. Eischen, Melissa A. Kacena & Lindsey D. Mayo. (2018) The proto‐oncogene function of Mdm2 in bone. Journal of Cellular Biochemistry 119:11, pages 8830-8840.
Crossref
Crossref
Rameez Raja, Larance Ronsard, Sneh Lata, Shubhendu Trivedi & Akhil C. Banerjea. (2017) HIV-1 Tat potently stabilises Mdm2 and enhances viral replication. Biochemical Journal 474:14, pages 2449-2464.
Crossref
Crossref
Ann-Sofie B. Brier, Anne Loft, Jesper G. S. Madsen, Thomas Rosengren, Ronni Nielsen, Søren F. Schmidt, Zongzhi Liu, Qin Yan, Hinrich Gronemeyer & Susanne Mandrup. (2017) The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiation. Nucleic Acids Research 45:4, pages 1743-1759.
Crossref
Crossref
Xenia VillalobosLaura RodríguezAnna SoléCarolina LliberósNúria MenciaCarlos J. CiudadVéronique Noé. (2015) Effect of Polypurine Reverse Hoogsteen Hairpins on Relevant Cancer Target Genes in Different Human Cell Lines. Nucleic Acid Therapeutics 25:4, pages 198-208.
Crossref
Crossref
Shuko Harada, Shi Wei & Gene P. Siegal. 2015. Bone Cancer. Bone Cancer
213
222
.
Jan B. Egan, Michael T. Barrett, Mia D. Champion, Sumit Middha, Elizabeth Lenkiewicz, Lisa Evers, Princy Francis, Jessica Schmidt, Chang-Xin Shi, Scott Van Wier, Sandra Badar, Gregory Ahmann, K. Martin Kortuem, Nicole J. Boczek, Rafael Fonseca, David W. Craig, John D. Carpten, Mitesh J. Borad & A. Keith Stewart. (2014) Whole Genome Analyses of a Well-Differentiated Liposarcoma Reveals Novel SYT1 and DDR2 Rearrangements. PLoS ONE 9:2, pages e87113.
Crossref
Crossref
Courtney H. Coschi & Frederick A. Dick. (2012) Chromosome instability and deregulated proliferation: an unavoidable duo. Cellular and Molecular Life Sciences 69:12, pages 2009-2024.
Crossref
Crossref
Xavier C. Badoux, Michael J. Keating & William G. Wierda. (2010) What is the Best Frontline Therapy for Patients with CLL and 17p Deletion?. Current Hematologic Malignancy Reports 6:1, pages 36-46.
Crossref
Crossref
Laurent Castéra, Audrey Sabbagh, Catherine Dehainault, Dorothée Michaux, Audrey Mansuet-Lupo, Blandine Patillon, Estelle Lamar, Isabelle Aerts, Livia Lumbroso-Le Rouic, Jérôme Couturier, Dominique Stoppa-Lyonnet, Marion Gauthier-Villars & Claude Houdayer. (2010) MDM2 as a Modifier Gene in Retinoblastoma. JNCI: Journal of the National Cancer Institute 102:23, pages 1805-1808.
Crossref
Crossref
Walter C. Bell & Gene P. Siegal. 2010. Bone Cancer. Bone Cancer
193
199
.
Grzegorz Sarek & Päivi M. Ojala. 2010. Molecular Basis for Therapy of AIDS-Defining Cancers. Molecular Basis for Therapy of AIDS-Defining Cancers
167
180
.
Dana-Lynn T. Koomoa, Tamas Borsics, David J. Feith, Craig C. Coleman, Christopher J. Wallick, Ivonne Gamper, Anthony E. Pegg & André S. Bachmann. (2009)
Inhibition of
S
-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma
. Molecular Cancer Therapeutics 8:7, pages 2067-2075.
Crossref
Crossref
Zhong-Zong Pan & Andrew K. Godwin. 2006. Encyclopedia of Molecular Cell Biology and Molecular Medicine. Encyclopedia of Molecular Cell Biology and Molecular Medicine.
Yetao Jin, Shelya X. Zeng, Hunjoo Lee & Hua Lu. (2004) MDM2 Mediates p300/CREB-binding Protein-associated Factor Ubiquitination and Degradation. Journal of Biological Chemistry 279:19, pages 20035-20043.
Crossref
Crossref
Dorota Dworakowska, Ewa Jassem, Jacek Jassem, Brigitte Peters, Rafał Dziadziuszko, Maciej Żylicz, Joanna Jakóbkiewicz-Banecka, Grażyna Kobierska-Gulida, Amelia Szymanowska, Jan Skokowski, Albert Roessner & Regine Schneider-Stock. (2004) MDM2 gene amplification: a new independent factor of adverse prognosis in non-small cell lung cancer (NSCLC). Lung Cancer 43:3, pages 285-295.
Crossref
Crossref
A. El-Meghawry El-Kenawy, A.F. El-Kott & A.M. Khalil. (2018) Prognostic value of p53 and MDM2 Expression in Bilharziasis-Associated Squamous Cell Carcinoma of the Urinary Bladder. The International Journal of Biological Markers 18:4, pages 284-289.
Crossref
Crossref
Ling Ren, Daryl Emery, Barbara Kaboord, Edith Chang & M.Walid Qoronfleh. (2003) Improved immunomatrix methods to detect protein:protein interactions. Journal of Biochemical and Biophysical Methods 57:2, pages 143-157.
Crossref
Crossref
Gordon D. Strachan, Kelly L. Jordan‐Sciutto, Ravikumar Rallapalli, Rocky S. Tuan & David J. Hall. (2002) The E2F‐1 transcription factor is negatively regulated by its interaction with the MDMX protein. Journal of Cellular Biochemistry 88:3, pages 557-568.
Crossref
Crossref
Lucio Lara Santos, Marta Koch Pereira, Céu Silva Costa, Teresina Pinto Amaro, Catarina Reis Lameiras, Sofía Alves Pereira, Paula Silva Lopes, Begoña Criado Alonso, Alberto Carlos Koch & Carlos Silva Lopes. (2002) The prognostic value of MDM2 overexpression in superficial urothelial bladder carcinomaValor pronóstico de la sobreexpresión de MDM2 en carcinomas uroteliales superficiales de vejiga. Revista de Oncología 4:6, pages 322-326.
Crossref
Crossref
Henry Pitot & Daniel Loeb. 2002. Fundamentals of Oncology, Revised and Expanded. Fundamentals of Oncology, Revised and Expanded
643
695
.
F Sandra, N Nakamura, T Kanematsu, M Hirata & M Ohishi. (2002) The role of MDM2 in the proliferative activity of ameloblastoma. Oral Oncology 38:2, pages 153-157.
Crossref
Crossref
Sonia Arora, Robin Mathew, Meera Mathur, Tushar Kant Chattopadhayay & Ranju Ralhan. (2001) Alterations in MDM2 expression in esophageal squamous cell carcinoma: Relationship with p53 status. Pathology & Oncology Research 7:3, pages 203-208.
Crossref
Crossref
Corinne CapouladeLluis M. MirKarine CarlierYann LécluseCécile TétaudZohair MishalJoëlle Wiels. (2001) Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides. Blood 97:4, pages 1043-1049.
Crossref
Crossref
Gitali Ganguli, Joseph Abecassis & Bohdan Wasylyk. (2000) MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis. The EMBO Journal 19:19, pages 5135-5147.
Crossref
Crossref
V Favaudon. (2000) Régulation du cycle cellulaire et de la mort cellulaire radio-induite. Cancer/Radiothérapie 4:5, pages 355-368.
Crossref
Crossref
V. G. Gorgoulis, P. Zacharatos, A. Kotsinas, G. Mariatos, T. Liloglou, T. Vogiatzi, P. Foukas, G. Rassidakis, G. Garinis, T. Ioannides, V. Zoumpourlis, J. Bramis, P. O. Michail, P. J. Asimacopoulos, J. K. Field & Ch. Kittas. (2000) Altered Expression of the Cell Cycle Regulatory Molecules pRb, p53 and MDM2 Exert a Synergetic Effect on Tumor Growth and Chromosomal Instability in Non-small Cell Lung Carcinomas (NSCLCs). Molecular Medicine 6:3, pages 208-237.
Crossref
Crossref
Jamil Momand, Hsiao-Huei Wu & Gargi Dasgupta. (2000) MDM2 — master regulator of the p53 tumor suppressor protein. Gene 242:1-2, pages 15-29.
Crossref
Crossref
Nik Veldhoen, Su Metcalfe & Jo Milner. (1999) A novel exon within the mdm2 gene modulates translation initiation in vitro and disrupts the p53-binding domain of mdm2 protein. Oncogene 18:50, pages 7026-7033.
Crossref
Crossref
Scott E. Seavey, Marisa Holubar, Leslie J. Saucedo & Mary Ellen Perry. (1999)
The E7 Oncoprotein of Human Papillomavirus Type 16 Stabilizes p53 through a Mechanism Independent of p19
ARF
. Journal of Virology 73:9, pages 7590-7598.
Crossref
Crossref
Christine Wasylyk, Roberto Salvi, Manuela Argentini, Christine Dureuil, Isabelle Delumeau, Joseph Abecassis, Laurent Debussche & Bohdan Wasylyk. (1999) p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53. Oncogene 18:11, pages 1921-1934.
Crossref
Crossref
M Alkhalaf, G Ganguli, N Messaddeq, M Le Meur & B Wasylyk. (1999) MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice. Oncogene 18:7, pages 1419-1434.
Crossref
Crossref
Emma L Arriola, Ana Rodriguez Lopez & Christine M Chresta. (1999) Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop. Oncogene 18:4, pages 1081-1091.
Crossref
Crossref
Hans-Udo Kasper, Regine Schneider-Stock, Walter Mellin, Thomas Günther & Albert Roessner. (1999) P53-Protein Accumulation and MDM2-Protein Overexpression in Gastric Carcinomas. No Apparent Correlation with Survival. Pathology - Research and Practice 195:12, pages 815-820.
Crossref
Crossref
Vassilis G. Gorgoulis, Panayotis Zacharatos, Athanassios Kotsinas, Triantofillos Liloglou, Aspasia Kyroudi, Marinos Veslemes, Antonios Rassidakis, Thanos D. Halazonetis, John K. Field & Christos Kittas. (1998) Alterations of the p16-pRb Pathway and the Chromosome Locus 9p21?22 in Non-Small-Cell Lung Carcinomas. The American Journal of Pathology 153:6, pages 1749-1765.
Crossref
Crossref
Thierry L?veillard, Philippe Gorry, Karen Niederreither & Bohdan Wasylyk. (1998) MDM2 expression during mouse embryogenesis and the requirement of p53. Mechanisms of Development 74:1-2, pages 189-193.
Crossref
Crossref
M. R. Hilleman. 1998. Genes and Environment in Cancer. Genes and Environment in Cancer
345
362
.